ARCHIVES

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Foundation Supports Chicago Researchers

September 10, 1993

825,000 Pounds of Yew Bark Clleced in ’91 For 10,000 Patients

March 13, 1992

DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer

November 9, 1984